Uterine Fibroid Treatment Drugs Market Is Expected To Reach $ 3.91 Billion By 2030


 San Francisco, 17 Aug 2023: The Report Uterine Fibroid Treatment Drugs Market Size, Share & Trends Analysis Report By Drug Class (GnRH Agonists, GnRH Antagonists), By Type (Submucosal Fibroids, Intramural Fibroids), By End-user, And Segment Forecasts, 2023 - 2030

The global uterine fibroid treatment drugs market size is expected to reach USD 3.91 billion by 2030, expanding at a CAGR of 10.2% from 2022 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the rising prevalence of Uterine Fibroids (UF) and the increased effectiveness of novel drugs in reducing heavy menstrual bleeding in women. According to an article published on IntechOpen, heavy menstrual bleeding is a common symptom of uterine fibroids affecting approximately 1.4 million women per year. In addition, nearly 60% of women report that symptoms impede physical activity and affect their quality of life. Moreover, 24% of women reported that symptoms prevent them from performing to their full ability at work.

Therefore, the rising demand for novel drugs with an advanced mechanism of action, higher clinical efficacy & lesser side effects is expected to drive the market. In addition, rising funding for research activities is expected to boost market growth. For instance, the Society for Women’s Health Research (SWHR) endorsed the updated & re-introduced Stephanie Tubbs Jones Uterine Fibroid Research & Education Act of 2021. The act is designed to advance funding for research and enhance education regarding the condition. The recent approval of multiple Gonadotropin-releasing Hormone (GnRH) antagonists for the treatment of heavy bleeding associated with fibroids will also drive the market. For instance, in May 2020, the U.S. FDA approved Oriahnn for the treatment of uterine fibroids.

It became the first oral medication approved for the treatment of heavy bleeding in pre-menopausal women. The drug has a treatment duration of 24 months and is available at a retail price of USD 1,100 for 56 tablets. Furthermore, key players are focusing on new launches, mergers & acquisitions, expansion, and partnerships for gaining higher market shares. For instance, in June 2022, Kissei Pharmaceuticals announced the initiation of Phase III trials for its drug, linzagolix, for the treatment of uterine fibroids, in Japan. The drug has already been approved by EMA under the brand name Yselty in Europe. The original developer, ObsEva, sold the regional rights for this drug to Theramex in Feb 2022. The deal grants Theramex the rights to sell this drug in Europe, Brazil, and Australia.

Access Research Report of Uterine Fibroid Treatment Drugs Market @ https://www.grandviewresearch.com/industry-analysis/uterine-fibroid-treatment-drugs-market-report

Uterine Fibroid Treatment Drugs Market Report Highlights

  • The GnRH antagonists segment is expected to register the fastest growth rate over the forecast period
  • The recent approval of multiple drugs, such as Oriahnn in May 2020 in the U.S., Myfembree in May 2021 in the U.S., and Yselty in June 2022 in Europe, is expected to drive market growth
  • The submucosal fibroids segment held the majority of the share of the UF drugs market in 2022
  • Retail pharmacies dominated the market in 2022 on account of the ease of availability of medications in these pharmacies
  • North America held the largest share of the global market in 2022 due to various factors, such as the presence of major players, the high prevalence of the health condition, and increasing awareness among patients regarding the availability of medications

Uterine Fibroid Treatment Drugs Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 2.0 billion

Revenue forecast in 2030

USD 3.91 billion

Growth rate

CAGR of 10.2% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

List of Key Players in Uterine Fibroid Treatment Drugs Market

  • Myovant Sciences GmbH
  • Pfizer Inc.
  • Abbvie, Inc.
  • Ferring B.V.
  • AstraZeneca
  • Bayer AG
  • Amring Pharmaceuticals Inc.
  • Watson Pharma, Inc.

Access Press Release of Uterine Fibroid Treatment Drugs Market @ https://www.grandviewresearch.com/press-release/global-uterine-fibroid-treatment-drugs-market

 

Comments

Post a Comment

Popular posts from this blog

U.K. Point Of Sale Software Market To Expand Industry Growth At USD 1.05 Billion By 2028

Image
  San Francisco, 21 Jan 2022:   The Report  U.K. Point Of Sale Software Market  Size, Share & Trends Analysis Report By Application (Fixed POS, Mobile POS), By Deployment, By Organization Size, By End-user, And Segment Forecasts, 2021 - 2028 The global U.K. point of sale software market size is expected to reach USD 1.05 billion by 2028, expanding at a CAGR of 8.1% from 2021 to 2028, according to the new study conducted by Grand View Research, Inc. The integration of a Point-Of-Sale (POS) solution with capabilities such as sales reports monitoring, cash flow recording, product demand analysis, tracking delivery status, and inventory management ensure systematic functioning and upscaling of a business. The adoption of POS software is directly impacted by the demand for POS terminals, which is witnessing growth in demand due to changing lifestyles and government policies. However, the COVID-19 pandemic disrupted the industry's business, wherein ...
Read more

Gas Detection Equipment Market Anticipated To Expand At A CAGR 9.7% From 2021 To 2028

  San Francisco, 5 May 2021:   The Report  Gas Detection Equipment Market  Size, Share & Trends Analysis Report By Product, By Technology (Infrared, Catalytic, PID), By End-use, By Region, And Segment Forecasts, 2021 - 2028 The global gas detection equipment market size is expected to reach USD 8.38 billion by 2028, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 9.7% from 2021 to 2028. The market growth can be attributed to the growing awareness among governments regarding the harmful effects of greenhouse gases, coupled with their increased efforts toward protecting the environment. Major industries such as petroleum, oil, and gas, among others are needed to comply with safety and environmental regulations which are also major factors driving the market growth. Many companies are focused on introducing drone-based gas detection equipment, which is expected to create new opportunities for market growth in...
Read more